在接受药物治疗的前临床视障绿内障患者中增加了近附加功率
Masahiko Ayaki1, Akiko Hanyuda1, Kazuno Negishi1
1Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Clinical & experimental optometry
|September 29, 2025
概括
与对照组相比,年龄在30-39岁之间的青光眼患者经历了较早出现的长远视力,近距离增加功率较高,表明了这种情况. 这表明青光眼药物可能会加快长视障碍的进展.
科学领域:
- 眼科医生 眼科 眼科
- 眼镜测量是指眼睛的测量.
背景情况:
- 长视,与年龄相关的近距离聚焦能力的丧失,在青光眼患者中更早影响个体.
- 青光眼药物对长视的进展的影响尚不清楚.
研究的目的:
- 为了调查青光眼的药物是否加快了青光眼患者的视近视的进展.
- 为了比较使用药物与对照对象的玻璃眼病患者近添加功率的进展.
主要方法:
- 一项涉及187名对照组和106名青光眼患者 (年龄在30-39岁) 的回顾性横截面研究.
- 六个多月服用药物的青光眼患者与对照人群之间的近附加功率和眼睛参数的比较.
- 分析包括无变量回归和卡普兰-梅尔生存分析.
主要成果:
- 与对照组相比,青光眼患者的平均近增强功率 (1.61 D vs 0.91 D) 和近增强功率≥ 1.50 D (51.9% vs 20.9%) 的患病率显著更高.
- 青光眼患者比对照患者早得多地达到+1.50 D的近附加功率的终点.
- 年龄,近视错误,纹,异视,斑点厚度,质细胞复合体厚度和视网膜神经纤维层厚度与对照中的近添加功率有关.
结论:
- 与年龄相匹配的对照人群相比,年龄在30-39岁之间的青光眼患者表现出明显的接近增强功率.
- 研究结果表明,青光眼患者的长远视力进展可能加速,可能与青光眼药物有关.
- 这些结果可能会为患有早发近视症的青光眼患者提供改进的管理策略.
相关概念视频
01:27Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
01:28Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
01:25Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
01:16Focusing of Light in the Eye
5.4K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
5.4K
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
228
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
228
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.4K